Table 5.
Distribution of bone metastasis positivity according to existence of estrogen and progesterone receptors and HER2 protein levels
| Characteristic | Bone Metastasis | p value | |
|---|---|---|---|
|
| |||
| (+) | (-) | ||
| IDC | |||
| Estrogen Receptor (ER) | 0.482 | ||
| Positive | 119 | 630 | |
| Negative | 24 | 153 | |
| Progesterone Receptor (PgR) | 0.824 | ||
| Positive | 106 | 569 | |
| Negative | 37 | 214 | |
| HER2 | 0.818 | ||
| Positive | 23 | 135 | |
| Negative | 107 | 569 | |
| Indefinite | 13 | 79 | |
| IL-DC | |||
| Estrogen Receptor (ER) | |||
| Positive | 17 | 63 | 0.909 |
| Negative | 3 | 7 | |
| Progesterone Receptor (PgR) | |||
| Positive | 16 | 53 | 0.815 |
| Negative | 4 | 17 | |
| HER2 | |||
| Positive | 0 | 8 | |
| Negative | 18 | 59 | 0.491 |
| Indefinite | 2 | 3 | |
| ILC | |||
| Estrogen Receptor (ER) | |||
| Positive | 11 | 48 | 0.521 |
| Negative | 0 | 4 | |
| Progesterone Receptor (PgR) | |||
| Positive | 8 | 45 | 0.605 |
| Negative | 3 | 7 | |
| HER2 | |||
| Positive | 0 | 2 | |
| Negative | 10 | 49 | 0.727 |
| Indefinite | 1 | 1 | |
IDC: Invasive Ductal Carcinoma; IL-DC: Invasive Lobular-Ductal Carcinoma; ILC: Invasive Lobular Carcinoma; HER2: Human Epidermal Growth Factor Receptor 2.